Interfractional Rectal Displacement Requiring Repeated Precaution Did Not Correlate to Biochemical Control and Rectal Toxicity in Patients with Prostate Cancer Treated with Image-guided Intensity-modulated Radiation Therapy

被引:1
作者
Iwama, Kazuki [1 ]
Yamazaki, Hideya [1 ,2 ]
Shimizu, Daisuke [1 ,2 ]
Suzuki, Gen [2 ]
Nakamura, Satoaki [2 ]
Sasaki, Naomi [2 ]
Takeneka, Tadashi [2 ]
Okabe, Haruumi [1 ]
Nishikawa, Tatsuyuki [1 ]
Yoshida, Ken [3 ]
机构
[1] Ujitakeda Hosp, Dept Radiol, Uji, Japan
[2] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Radiol, Kamigyo, Japan
[3] Osaka Med Coll, Dept Radiol, Takatsuki, Osaka, Japan
关键词
Tomotherapy; prostate cancer; IG-IMRT; late toxicity; biochemical control; HELICAL TOMOTHERAPY; ORGAN MOTION; RADIOTHERAPY; GUIDANCE; MARKERS;
D O I
10.21873/anticanres.12015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To investigate the correlation between frequency of action level of interfractional rectal displacement requiring repeated precaution in patients with prostate cancer and late toxicity from image-guided intensity-modulated radiation therapy (IG-IMRT) using helical tomotherapy. Patients and Methods: We examined 264 patients who underwent IG-IMRT during 2007-2011. Megavoltage computed tomographic (MVCT) images were acquired before radiation therapy and was examined with soft-tissue matching by comparing treatment planning images within 9,345 fractions. Displacement of the anterior rectal region larger than 5 mm, requiring repeated precaution, was defined as the level of rectal displacement requiring action (ARD). Results: ARD was identified in 815 (7.7%) out of 9,345 fractions and at least once in 82% (216/264) of patients. The highest incidence of ARD (11%) was found during the initial week of treatment (first five and next five fractions), after which the incidence decreased to 6% (p<0.0001). Patients with lean body (lower body mass index (BMI) tended to have a higher incidence of ARD. We identified 16 (6%) cases of gastrointestinal toxicity and 12 (4.5%) genitourinary toxicities as a late adverse reaction (3 months or later after IG-IMRT). There was no correlation between ARD and late toxicity. Prostate-specific antigen (PSA) control was also similar (p=0.12) between those with ARD (96% at 5 year) and those without ARD (88%). Conclusion: ARD occurred predominantly in lean patients, during the initial week of treatment and became less likely over time. ARD was not correlated to late toxicity and PSA control, therefore, IG-IMRT technique was able to adequately control error due to interfractional prostate and rectal motion.
引用
收藏
页码:5755 / 5760
页数:6
相关论文
共 21 条
  • [1] Bell LJ, 2017, J MED RADIAT SCI, V64, P25, DOI 10.1002/jmrs.224
  • [2] Intensity-modulated radiotherapy using implanted fiducial markers with daily portal imaging: Assessment of prostate organ motion
    Chen, Jergin
    Lee, R. Jeffrey
    Handrahan, Diana
    Sause, William T.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (03): : 912 - 919
  • [3] Evidence of limited motion of the prostate by carefully emptying the rectum as assessed by daily MVCT image guidance with helical tomotherapy
    Fiorino, Claudio
    Di Mum, Nadia
    Broggi, Sara
    Cozzarini, Cesare
    Maggiulli, Eleonora
    Alongi, Filippo
    Valdagni, Riccardo
    Fazio, Ferruccio
    Calandrino, Riccardo
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (02): : 611 - 617
  • [4] The effect of bowel preparation regime on interfraction rectal filling variation during image guided radiotherapy for prostate cancer
    Hosni, Ali
    Rosewall, Tara
    Craig, Timothy
    Kong, Vickie
    Bayley, Andrew
    Berlin, Alejandro
    Bristow, Robert
    Catton, Charles
    Warde, Padraig
    Chung, Peter
    [J]. RADIATION ONCOLOGY, 2017, 12
  • [5] Iwama K, 2014, ANTICANCER RES, V34, P7373
  • [6] Iwama K, 2013, ANTICANCER RES, V33, P5675
  • [7] Dosimetric Comparison of Image Guidance by Megavoltage Computed Tomography versus Bone Alignment for Prostate Cancer Radiotherapy
    Kalz, Joern
    Sterzing, Florian
    Schubert, Kai
    Sroka-Perez, Gabriele
    Debus, Juergen
    Herfarth, Klaus
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 (04) : 241 - 247
  • [8] Acute and late complications after hypofractionated intensity modulated radiotherapy in prostate cancer
    Kozuka, Takuyo
    Nakano, Masahiro
    Hashimoto, Masatoshi
    Gomi, Kotaro
    Murofushi, Keiko Nemoto
    Sumi, Minako
    Yonese, Junji
    Oguchi, Masahiko
    [J]. JAPANESE JOURNAL OF RADIOLOGY, 2017, 35 (05) : 269 - 278
  • [9] Evaluation of image-guidance strategies in the treatment of localized prostate cancer
    Kupelian, Patrick A.
    Lee, Choonik
    Langen, Katja M.
    Zeidan, Omar A.
    Mawn, Rafael R.
    Willoughby, Twyla R.
    Meeks, Sanford L.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (04): : 1151 - 1157
  • [10] Long-term outcomes of a phase II trial of moderate hypofractionated image-guided intensity modulated radiotherapy (IG-IMRT) for localized prostate cancer
    Lieng, Hester
    Pintilie, Melania
    Bayley, Andrew
    Berlin, Alejandro
    Bristow, Robert
    Chung, Peter
    Gospodarowicz, Mary
    Huang, Roger
    Menard, Cynthia
    Warde, Padraig
    Catton, Charles
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 122 (01) : 93 - 98